Does the Medicare GLP-1 Bridge apply to Medicare Advantage plans?

Yes. Plans that provide Medicare drug coverage — including Medicare Advantage plans with built-in Part D (MA-PD plans) — participate in the Bridge automatically. If you meet the eligibility criteria and your doctor's prior authorization is approved, you pay the same flat $50 monthly copay as someone on Original Medicare with a standalone Part D plan.

Do I need to switch out of Medicare Advantage to get the $50 GLP-1 copay?

No. Because MA-PD plans participate in the Bridge automatically, there is no need to switch to Original Medicare plus a standalone Part D plan just to access the program. The Bridge copay and eligibility rules are the same either way.

Does my Medicare Advantage plan's formulary matter for the Bridge?

The Bridge sets its own covered-drug list (Wegovy injectable and oral, Zepbound KwikPen, and others) and its own flat $50 copay, so your plan's tier placement doesn't change the Bridge price. Your plan's formulary still matters for GLP-1s covered outside the Bridge — for example, Ozempic or Mounjaro prescribed for type 2 diabetes — and for pharmacy network rules.

Do Bridge copays count toward my Medicare Advantage plan's drug cap?

No. The $50 Bridge copay does not count toward the $2,100 Part D out-of-pocket cap (2026) or your deductible, because the Bridge operates alongside the Part D benefit rather than inside it. Budget it as a separate $600-per-year expense.

Do Medicare Advantage Plans Cover GLP-1s? The 2026 Bridge Changes Everything

Until this summer, GLP-1 coverage in Medicare Advantage was a formulary lottery. Since July 1, 2026, the GLP-1 Bridge applies to MA drug plans automatically — a flat $50 a month for eligible members. Here's what changed, and which plan rules still matter.

By GLP1Bridge Editorial · Published June 26, 2026 · Updated July 6, 2026

If you have a Medicare Advantage plan, the GLP-1 coverage question just got a dramatically better answer. As of July 1, 2026, the Medicare GLP-1 Bridge — the program offering weight-loss GLP-1s for a flat $50 monthly copay — applies to Medicare Advantage members too. Plans that provide Medicare drug coverage participate automatically, so there's nothing to switch, add, or purchase.

That headline change doesn't make your plan's own rules irrelevant, though. GLP-1s prescribed for diabetes or cardiovascular disease still run through your plan's regular formulary, tiers, and pharmacy network — and those vary a lot from plan to plan. This guide covers both layers: what the Bridge now guarantees every MA member, and what still depends on the plan you picked.

The big change: the Bridge applies to Medicare Advantage automatically

The single most important fact for MA members in 2026: you do not need Original Medicare to get the $50 GLP-1 copay. The Bridge was designed so that plans providing Medicare drug coverage — standalone Part D plans and Medicare Advantage plans with built-in drug coverage (MA-PD plans) — participate automatically. There is no separate enrollment, no opt-in form, and no premium change tied to the program.

To use it, an MA member follows the same path as anyone else:

Qualify through one of the three eligibility doors — BMI 35+; BMI 30+ with certain uncontrolled conditions (heart failure, hypertension, chronic kidney disease); or BMI 27+ with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. Our eligibility wizard walks you through it.
Get a prior authorization approved. Your prescriber must attest the drug is for weight management. This PA goes through your MA plan, but the criteria are the program's, not the plan's. See the step-by-step application guide.
Pay the flat $50 at the pharmacy. No deductible, no coinsurance, no tier math. The Bridge covers Wegovy (injectable and oral), the Zepbound KwikPen, and other listed drugs.

One budgeting note: the $50 Bridge copay does not count toward your plan's Part D deductible or the $2,100 annual out-of-pocket cap — the program runs alongside the regular drug benefit, not inside it. Here's how that math works. Also keep in mind the program is currently scheduled to run through December 31, 2027.

Sources: CMS.gov — Medicare GLP-1 Bridge program; KFF — Medicare GLP-1 coverage analysis.

What still depends on your plan: the diabetes and heart-disease pathways

Medicare Advantage (Part C) plans are offered by private insurers approved by Medicare, and most include Part D drug coverage built in. For GLP-1s prescribed for type 2 diabetes (Ozempic, Mounjaro) or an approved cardiovascular indication (Wegovy), the Bridge isn't involved — these run through your plan's regular formulary, and that's where plans differ substantially. One plan may place Ozempic on a preferred tier with a modest copay; another may use a higher tier with coinsurance. You can compare plans and their drug lists using the official Plan Finder on Medicare.gov.

Here's how the two pathways compare for an MA member in 2026:

	Bridge pathway (weight management)	Regular formulary pathway (diabetes / CV)
Monthly cost	Flat $50, every plan	Plan's copay/coinsurance — varies by plan and tier
Deductible applies?	No	Often yes, depending on plan/tier
Counts toward $2,100 cap?	No	Yes
Prior authorization	Yes — program criteria (weight-management attestation + eligibility door)	Yes — plan's own criteria (diagnosis, step therapy)
Varies between MA plans?	No — same nationwide	Yes — formulary, tiers, and restrictions differ

Illustrative — verify specifics with your plan. Formularies change yearly.

Where MA plans differ from Original Medicare

Formulary & tiers

Each MA-PD plan picks which GLP-1s it covers and on which tier. One plan may place Ozempic on a preferred tier with a modest copay; another may use a higher tier or not list it at all.

Prior authorization & networks

MA plans often apply their own prior-authorization and step-therapy rules, and they usually require in-network pharmacies. Using an out-of-network pharmacy can mean paying full price.

Source: CMS.gov — Medicare Advantage and Part D. Formulary details are set by each plan and change yearly.

What to look for when choosing a plan

If a GLP-1 medication matters to you — especially one taken for diabetes or heart disease, where the plan's own rules apply — treat the drug formulary as a top factor when comparing Medicare Advantage plans during open enrollment. Before you choose, check:

Is your specific drug on the formulary? Search by brand name in the plan's drug list. (Bridge drugs taken for weight loss are the exception — the $50 copay is the same in every plan.)
What tier is it on? The tier drives your copay or coinsurance.
Does it require prior authorization or step therapy? These can delay or block access.
Are there quantity limits? Limits can affect monthly supply.
Is your pharmacy in network? Preferred pharmacies often cost less.
What is the plan's overall out-of-pocket structure? Compare deductibles and the annual Part D cap.

Plans can change their formularies each year, so review your coverage every fall even if you are happy with your current plan. A drug that is covered this year may move tiers or drop off next year.

A practical approach

Make a short list of the exact medications you take, then run each one through the Plan Finder for every plan you are considering. Pay attention not just to whether a drug is covered, but to the tier and any restrictions. If two plans both cover your GLP-1, the one with the lower tier and fewer hurdles will usually save you money and hassle.

And if your GLP-1 is (or could be) prescribed for weight management, start with the Bridge: confirm you fit one of the three eligibility doors, then follow the application guide — the $50 copay beats almost any formulary tier. For a side-by-side look at common GLP-1s, see our covered drugs page, and estimate your total yearly costs with the cost calculator.

Check your GLP-1 eligibility first

Before comparing plans, confirm whether you qualify for coverage at all.

Check my eligibility →